Heartflow Reports Strong Q1 Results, Raises Full-Year Revenue and Gross Margin Guidance

summarizeSummary

Heartflow, Inc. announced strong first-quarter 2026 financial results, including 41% revenue growth and improved gross margins, leading to a raise in its full-year revenue and non-GAAP gross margin guidance.

check_boxKey Events

• Strong Q1 Revenue Growth

  Total revenue for the first quarter of 2026 reached $52.6 million, marking a 41% increase year-over-year.

• Improved Gross Margin

  The company reported a GAAP gross margin of 80.2%, an improvement from 75.1% in the prior year period, driven by increased volume and AI efficiency initiatives.

• Raised Full-Year Guidance

  Heartflow raised its full-year 2026 revenue guidance to $228 million - $232 million (29-32% growth) from the previous $218 million - $222 million (24-26% growth). Non-GAAP gross margin guidance was also raised to approximately 81%.

• Facilities Optimization Charge

  Net operating loss of $29.5 million included a $7.5 million non-cash impairment charge related to facilities optimization and headquarters relocation to San Francisco.

auto_awesomeAnalysis

Heartflow, Inc. reported robust first-quarter financial results, significantly exceeding prior-year performance and raising its full-year guidance. The company achieved 41% year-over-year revenue growth and improved gross margins, demonstrating strong market adoption of its AI technology for coronary artery disease. The raised revenue and gross margin outlook for 2026 signals management's increased confidence in continued growth and operational efficiency, which is critical for a company that has been operating at a net loss and accumulating a deficit.